Nishtha Sharma

Nishtha Sharma

Auto-generated profile, based on publicly available information

Nishtha Sharma

National Agri-Food Biotechnology Institute, Sector-81 (Knowledge City), S.A.S. Nagar, Mohali-140306, Punjab, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
LALuis Alvarado
Luis Alvarado
NSNishtha Sharma
Nishtha Sharma
RLRoxann Lerma
Roxann Lerma
ADAlok Kumar Dwivedi
Alok Kumar Dwivedi
AAAdeel Ahmad
Adeel Ahmad
EAEyas Alkhalili
Eyas Alkhalili
Background: Secondary hyperparathyroidism in patients with end stage renal disease on dialysis is associated with bone pain and fractures in addition to cardiovascular morbidity. Cinacalcet is the most commonly used drug to treat such patients, but it has never been compared to surgery. The goal of this study is to compare the long‐term outcomes and survival between cinacalcet and parathyroidectomy in the treatment of secondary hyperparathyroidism in hemodialysis patients.Methods: Adult patients on hemodialysis who were treated with cinacalcet or parathyroidectomy in the United States Renal Data System were included. Patients treated with surgery (n = 2023) were compared using 1:1 propensity score matching ratio to a cohort of patients treated with cinacalcet. A Cox regression analysis was conducted to compare the overall mortality.Results: The propensity score matching successfully created two groups with similar demographics. Patients in the surgery group had a higher mean peak PTH level prior to therapy (2066.8 vs 1425.4, P < 0.001). No difference was observed in the development of new‐onset coronary artery disease (7.7% vs 7.9%, P = 0.8) or cerebrovascular disease (7% vs 6.7%, P = 0.8). Surgical patients had a higher rate of pathologic fractures (27.8% vs 24.9%, P = 0.04). Survival analysis showed that patients undergoing surgery had a better 5‐year survival (65.6% vs 57.8%) and were less likely to die within the study period (HR 0.77, 95% CI 0.7–0.85, P < 0.0001).Conclusions: Patients on dialysis undergoing parathyroidectomy for the treatment of secondary hyperparathyroidism have a better overall survival than those treated with cinacalcet.

14 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNishtha Sharma
Nishtha Sharma
RKRaminder Kaur
Raminder Kaur
BYBinduma Yadav
Binduma Yadav
KSKoushik Shah
Koushik Shah
HPHarshita Pandey
Harshita Pandey
VRVikas Rishi
Vikas Rishi
Transformation of committed 3T3-L1 preadipocytes to lipid-laden adipocytes involves timely appearance of numerous transcription factors (TFs), foremost among them C/EBPβ, is expressed during early phases of differentiation. Here we describe liposome-mediated protein transfection approach to rapidly downregulate C/EBPβ by A-C/EBP protein inhibitor. Signals from tagged A-C/EBP were observed in 3T3-L1 cells within 2hrs of protein inhibitor transfections whereas for gene transfection signals appeared in 48hrs. Following transient transfections, expression profiles of 24 marker genes belonging to pro- and anti-adipogenic, cell cycle, and preadipocytes pathways was analyzed. mRNA and protein expression profiles of adipocyte-marker genes showed lower expression in both A-C/EBP protein and gene transfected samples. Interestingly, for preadipocytes and cell fate determinant genes, striking differences were observed between protein and gene transfected samples. Preadipocyte differentiation factors Stat5a and Creb were downregulated in A-C/EBP protein samples. Five preadipocyte markers, namely, Pdgfrα, Pdgfrβ, Ly6A, CD34 Itgb1 showed high expression in protein samples whereas only Ly6A and CD34 were expressed in gene transfected samples. Pdgfrα and Pdgfrβ , two known cell fate markers were expressed in protein transfected samples 5-days post-differentiation suggesting a possible reversal of differentiation. Our study provides evidences for the robust and efficient knockdown of C/EBPβ protein to understand time-dependent gene regulation during adipogenesis.

30 June 2022 in Research Square
Verified
Preprint
Open access
PDF file
KSKoushik Shah
Koushik Shah
RKRaminder Kaur
Raminder Kaur
NSNishtha Sharma
Nishtha Sharma
PJPrateek Jain
Prateek Jain
DSDalwinder Singh
Dalwinder Singh
VRVikas Rishi
Vikas Rishi
Sequence-specific transcription factor (TF)-DNA binding is a vital step in biology since it directly regulates genetic information inside the organism. However, the binding sites for many TFs are unknown in plants and animals.Using high-throughput sequencing technologies,studies have shown that TFs, including basic leucine zipper (bZIP), bind to a myriad of sequences, many of which are biologically relevant. bZIPs are eukaryote-specific dimeric TFs, and in plants, they are reported to bind to 8-12 nts sequences (with ACGT core) in the promoter region of many genes. In sedentary plants, they are the conduit for converting environmental cues into gene activity. A key question is what determines bZIP DNA binding specificity.This study adopts the Bind-n-seq methodology, which uses a 108 nts oligonucleotides library with an 18 nts random sequence that either incorporates ACGT tetranucleotides core or a completely random sequence to generate in vitro DNA-bZIP interaction maps of four seed-specific bread wheat bZIPs. Subsequently, de novo binding motifs representing the complete binding landscape for each bZIP were determined. Binding analysis shows a high degree of overlap for bZIP binding to G-box and C-box but with distinct flanking bases, suggesting a discrete role of flanking regions in ordaining TF-DNA binding specificity. From this study binding motifs obtained for Hy5 and Embp-1 show similarity with previously reported sequences, suggesting the protocol's robustness.